Reversible modulation of erythrocyte Ca2+ homeostasis: a possible role for dialyzable plasma factors derived from patients with end-stage renal disease
Dubyak, G.R.
Journal of Laboratory and Clinical Medicine 114(3): 211-212
1989
ISSN/ISBN: 0022-2143 PMID: 2671212 Document Number: 329588
Document emailed within 1 workday
Related Documents
Yamaguchi, S.; Gohda, T.; Gotoh, H.; Omote, K.; Furukawa, M.; Ishikawa, Y.; Tomino, Y. 2013: Factors associated with cardiovascular death and events in patients with end stage renal disease Nihon Jinzo Gakkai Shi 55(2): 159-166Nagaoki, T.; Moriya, N.; Miyawaki, T.; Seki, H.; Kubo, M.; Yokoi, T.; Okuda, N.; Taniguchi, N. 1980: Suppression of B cell differentiation by dialyzable humoral factors derived from pokeweed mitogen-stimulated cord T cells Journal of Immunology 125(4): 1563-1568
Chinprateep, B.; Ratanasit, N.; Chanchairujira, T. 2016: Prevalence and Factors Associated with Left Ventricular Systolic Dysfunction in End-Stage Renal Disease Patients on Dialysis Journal of the Medical Association of Thailand 99(6): 653-658
Wechpradit, A.; Thaiyuenwong, J.; Kanjanabuch, T. 2011: Health promotion behaviors and related factors in end stage renal disease patients treated with continuous ambulatory peritoneal dialysis Journal of the Medical Association of Thailand 94(Suppl 4): S113-S118
Azevedo, H.A.; Villela-Nogueira, C.A.; Perez, R.M.; Segadas-Soares, J.A.; Takahashi, C.; Gaburo, N.; Pessoa, I.; Coelho, H.Sérgio.M. 2007: Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function Journal of Nephrology 20(5): 609-616
Henry, M.L.; Ketel, B.L.; Elkhammas, E.A.; Tesi, R.J.; Ferguson, R.M. 1990: The role of transplantation in diabetics with end-stage renal disease Clinical Transplants 1990: 203-215
Taft, P.; Zimmet, P.; Ng, F.M.; Bornstein, J. 1972: Role of growth hormone-derived peptides, cataglykin and somantin in human glucose homeostasis Israel Journal of Medical Sciences 8(6): 865
Bargman, J.M. 1997: The role of Na,K-ATPase inhibitors in hypertension and end-stage renal disease Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 17(6): 536-540
Olin 1998: Is Survival Different for Renal Artery Stenosis Patients on Dialysis Compared to Others with End Stage Renal Disease? Journal of Invasive Cardiology 10(2): 105-108
Nissenson, A.R.; Port, F.K. 1990: Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders Quarterly Journal of Medicine 74(273): 63-74
Nissenson, A.R.; Port, F.K. 1989: Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders Quarterly Journal of Medicine 73(271): 1055-1062
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
Selivonenko, V.G.; Piasetskiĭ, I.S. 1971: Plasma and erythrocyte levels of calcium and magnesium in patients at various stages of hypertensive disease Sovetskaia Meditsina 34(5): 140-142
Lu, G.; Ouyang, S.; Pei, Z. 1999: Changes of erythrocyte membrane ATPase activities and plasma lipids in patients with coronary heart disease Hunan Yi Ke da Xue Xue Bao 24(1): 68-70
Shaked, A.; Thompson, M.; Wilkinson, A.H.; Nuesse, B.; el-Khoury, G.F.; Rosenthal, J.T.; Danovich, G.M.; Busuttil, R.W. 1993: The role of combined liver/kidney transplantation in end-stage hepato-renal disease American Surgeon 59(9): 606-609
Myburgh, J.A.; Botha, J.R.; Meyers, A.M.; Smit, J.A.; Milne, F.J.; Thomson, P.D.; Beale, P.; Seggie, J. 1983: The treatment of end-stage renal disease at the Johannesburg Hospital: a 17-year experience. Part II. the role of transplantation South African Medical Journal 64(14): 522-527
Meyers, A.M.; Furman, K.I.; Botha, J.R.; Milne, F.J.; Thomson, P.D.; Louridas, G.; Seggie, J.; Myburgh, J.A. 1983: The treatment of end-stage renal disease at the Johannesburg Hospital: a 17-year experience. Part I. the role of dialysis South African Medical Journal 64(14): 515-521
McCoy, K.L.; Goldstein, D.R.; Gahtan, V.; Mayro, G.; Kerstein, M.D. 2001: Peripheral vascular disease intervention in patients with end-stage renal disease: few complications in those treated with peritoneal dialysis Southern Medical Journal 94(10): 1002-1005
Bodson, A.; Meunier, P.; Krzesinski, J.-M.; Jouret, F. 2016: Autosomal Dominant Polycystic Kidney Disease: how and Why Should we Identify the Patients "rapidly Progressing" to End-Stage Renal Disease? Revue Medicale de Liege 71(4): 184-192
Kutyrina, I.M.; Rudenko, T.E.; Shvetsov, M.Iu.; Kushnir, V.V. 2006: Risk factors of vascular complications in patients at a predialysis stage of chronic renal failure Terapevticheskii Arkhiv 78(5): 45-50